Post

Intravascular Administration Sets and Accessories - Testing and Documentation Requirements

This guidance document covers intravascular (IV) administration sets and accessories classified under 21 CFR 880.5440 (Class II). This includes extension sets, IV stopcocks and manifolds, in-line filters, flow regulators, fluid delivery tubing, vial adapters, IV transfer sets, subcutaneous administration sets, blood administration sets, and transfusion filters. The guidance also covers IV administration sets with or without needleless access devices or systems.

  1. Conduct comprehensive risk analysis to identify all potential risks
  2. Develop and execute test protocols for:
    • Bench testing under dry and wet conditions
    • Microbial ingress testing if applicable
    • Simulated clinical use testing for safety features
    • Biocompatibility testing
  3. Prepare detailed device description including:
    • Material composition
    • Physical specifications
    • Mechanical specifications
    • Design features
  4. Validate sterilization process
  5. Develop comprehensive labeling including:
    • Intended use
    • Device description
    • Directions for use
    • Precautions and warnings
    • Storage conditions
  6. Document all testing results and risk mitigation measures in design history file
  7. Prepare 510(k) submission including all required testing data and documentation
  8. Ensure compliance with referenced standards where applicable

Key Considerations

Non-clinical testing

  • Bench testing under dry and wet conditions comparing to legally marketed devices
  • Testing should assess force to attach/detach connections, activate safety features
  • Testing of injection port accesses to failure
  • Pressure and leak tolerance testing
  • Flow characteristics testing

Human Factors

  • Simulated clinical use testing for devices with sharps injury prevention features
  • Assessment of variables like training, learning curve, user experience
  • Protocol should address patient and healthcare professional user populations

Labelling

  • Clear statement of intended use and target population
  • Device description including specifications
  • Step-by-step procedures for use
  • Special patient instructions
  • Cleaning and disinfection instructions
  • Precautions and warnings
  • Storage conditions
  • DEHP warnings if applicable

Biocompatibility

  • Testing as prolonged duration, indirect blood path contacting device
  • Selection of appropriate tests for duration and level of contact
  • Documentation of pass/fail criteria

Safety

  • Risk analysis to identify device-specific risks
  • Mitigation measures for identified risks:
    • Device malfunction
    • Adverse tissue reaction
    • Infection
    • Improper use

Other considerations

  • ISO 8536-4:2004: Infusion Equipment for Medical Use, Part 4
  • ANSI/AAMI BF7:R2002: American National Standard for Blood Transfusion Micro Filters
  • ISO 1135-4:2004: Transfusion Equipment for Medical Use
  • ISO 594: Conical Fittings with a 6% (Luer) Taper
  • ANSI/AAMI HE48-1993: Human factors engineering guidelines

Original guidance

  • Intravascular Administration Sets and Accessories - Testing and Documentation Requirements
  • HTML / PDF
  • Issue date: 2008-07-11
  • Last changed date: 2020-03-20
  • Status: FINAL
  • Official FDA topics: Medical Devices, 510(k), Premarket
  • ReguVirta summary file ID: e4f7343890963672e932a4587d3fad88
This post is licensed under CC BY 4.0 by the author.